No Data
No Data
Q3 Pharma and Biotech Layoffs in Charts: More Than 1000 Each in July and August
Why Levi Strauss Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarket
Market Perform Rating Maintained for AN2 Therapeutics Amidst Pipeline Potential and Phase 2 Setbacks
Analysts Offer Insights on Healthcare Companies: AN2 Therapeutics, Inc. (ANTX), MoonLake Immunotherapeutics (MLTX) and Ionis Pharmaceuticals (IONS)
Analysts Conflicted on These Healthcare Names: AN2 Therapeutics, Inc. (ANTX) and Roche Holding AG (OtherRHHVF)
JMP Securities Maintains AN2 Therapeutics(ANTX.US) With Buy Rating, Raises Target Price to $5
No Data
No Data